Description: This article describes Medicare Supplement and short-term care products in more detail, and we compare their risk profiles. We explore the concept that these two products—when offered together—may provide a complementary hedge of certain policyholder behavior risks.

Description: 1993 SOA Spring Meeting, Boston. This session is about the marketing front, including demographic trends, impact on products, market research, market segments and distribution.

Description: In this editorial the author discusses how actuaries can help mitigate the impact of managed care lawsuits. Examples are provided. From: The Actuary, April 2000 – volume 34 - Issue 4.

Description: The big event of 2023 is the launch of multiple Humira biosimilars, which began in January with the arrival of Amgen’s Amjevita on the market. The launch of Amjevita kicks off the process of changing the specialty drug marketplace in the United States. The expectation of the full impact of this big event is very hopeful, but there is still uncertainty several months after its beginning. Humira is the highest-selling drug in the world and has been since 2013 (Figure 1)—except for when COVID-19 projects temporarily surpassed it. The world is eagerly awaiting the launch of multiple biosimilar drugs to compete with Humira and hopefully bring more competitive pricing to the benefit of payers and patients everywhere.

Description: More and more providers are desiring risk-based contracts instead of traditional FFS-based contracts. This session is intended to outline some of the actuarial best practices in risk-based contracting related to the many flavors of the CMS ACO programs, as well as Commercial risk-based contracts.

Description: 1992 SOA Regional Meeting, Chicago. This discussion is about direct marketing growth in the 1980s, sustaining the growth in the 1990s, regulatory constraints in the 1990s, impact of continuing production cost increases, new product designs, and declining response rate.

Description: 1992 SOA Regional Meeting, Anaheim. This session addressed the product management actuary and the product management process. Topics discussed : 1. The monitoring of the environment and how that monitoring leads to the generation of ideas. 2. Consideration of how those ideas are affected by distribution, marketing, and organizational issues. 3. The setting of assumptions. 4. How to get different areas of your company to work together, and ways to bring the product to market as quickly as possible. 5. How to manage business once your company places it on the books.

Description: 1993 SOA Spring Meeting, San Diego. This session was about the Latin-American insurance market. Topics included: 1. Size, growth, regulations, products, distribution, marketing. 2. Market entry, business strategies, cultural issues, local staffing. 3. Level of activity for U.S. companies.

Description: 1959 SOA Regional Meeting in Atlanta. This discussion covered the advantages and disadvantages of entering the pension field through Ordinary policies or Group Annuities. The panel also discussed considerations in entering the Accident and Sickness field.

Description: Essay reforming healthcare where participants have a vested interest in reaching the best answer.